𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin’s Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study

✍ Scribed by Fan Yang, Huan-Ling Zhu, Chuan He…

Book ID
120959546
Publisher
Springer-Verlag
Year
2012
Tongue
English
Weight
356 KB
Volume
30
Category
Article
ISSN
0971-4502

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A revisit of prophylactic lamivudine for
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
✍ Chiun Hsu; Chao A. Hsiung; Ih-Jen Su; Wei-Shou Hwang; Ming-Chung Wang; Sheng-Fun 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

Lamivudine is effective to control hepatitis B virus (HBV) reactivation in HBV-carrying cancer patients who undergo chemotherapy, but the optimal treatment protocol remains undetermined. In this study, HBV carriers with newly diagnosed non-Hodgkin's lymphoma (NHL) who underwent chemotherapy were ran

P168 Hepatitis B virus reactivation in a
P168 Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with immuno-chemotherapy (including fludarabine and rituximab)
✍ Zs. Ujj; L. Rejtö; I. Tornai; A. Kiss; B. Telek; Gy. Reményi; P. Ilonczai; M. Ud 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 45 KB

was longer on retreatment (11 months) than at first treatment (6 months). It is of special interest, that this patient was 83 years old when treated first with radioimmunotherapy and tolerated it on both occasions without side effects or severe cytopenias. In another patient with severe accompanying